Methods and systems for DNA isolation on a microfluidic device

    公开(公告)号:US09938519B2

    公开(公告)日:2018-04-10

    申请号:US14833836

    申请日:2015-08-24

    Inventor: Michele R. Stone

    CPC classification number: C12N15/1003 G01N1/34

    Abstract: The present invention relates to methods and systems for the isolation of DNA on a microfluidic device and the subsequent analysis of the DNA on the microfluidic device. More specifically, embodiments of the present invention relate to methods and systems for the isolation of DNA from patient samples on a microfluidic device and use of the DNA for performing amplification reactions, such as PCR, and detection, such as thermal melt analysis, on the microfluidic.

    BIOLOGICAL TISSUE GRINDING CONTAINER
    47.
    发明申请

    公开(公告)号:US20180066247A1

    公开(公告)日:2018-03-08

    申请号:US15696477

    申请日:2017-09-06

    CPC classification number: C12N15/1003 B02C17/14 B02C19/16 C12M45/02

    Abstract: According to one embodiment, a biological tissue grinding container includes a container portion and a vibrated portion, and vibration is transmitted to biological tissue from the vibration portion to grind the biological tissue. The vibrated portion includes a contact portion to be brought into direct contact with the biological tissue and defines a chamber which stores the biological tissue to be ground, together with the container portion. The vibrated portion is fixedly supported to be vibratable to the container portion directly or via a support portion provided between the container portion and itself, and has solidity higher than that of the container portion or support portion.

    METHOD OF PARTIAL LYSIS AND ASSAY
    50.
    发明申请

    公开(公告)号:US20180031453A1

    公开(公告)日:2018-02-01

    申请号:US15730172

    申请日:2017-10-11

    Applicant: Hologic, Inc.

    Abstract: The present disclosure describes a method of treating a sample comprising cells with a process of partial lysing. Cells are exposed to a process such as bead beating that lyses some cells in the mixture. The process generates a resultant sample mixture that is suitable for both cell morphology screening and genetic screening. A first portion of the partially lysed sample can be mounted on a slide and observed for atypical cells and cytologic abnormalities. A second portion of the partially lysed sample can be screened for genetic markers known to correlate with a risk of cervical cancer. The method is particularly useful for cervical screening, where a combination of cytology and genetic screening present a more complete picture of cervical health. The disclosed method streamlines the diagnostic process for protocols that require both types of assays, without compromising screening accuracy.

Patent Agency Ranking